Robuta

https://pubmed.ncbi.nlm.nih.gov/26951379/ AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients... Single-agent bevacizumab may have a role in patients with recurrent glioblastoma.